Brittany Rosener

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Escherichia Coli

Network Analysis

Colorectal Cancer Screening

Top Venues

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) (2024)
Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) 384 (6691) (2024)
Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) 384 (6691) (2024)
Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) (2024)
Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) 384 (6691) (2024)
Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) 384 (6691) (2024)
Mariana Noto Guillen, Carmen G Li, Brittany Rosener, Amir Mitchell
Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics. Science (New York, N.Y.) 384 (6691) (2024)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. eLife 12 (2023)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. eLife 12 (2023)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. eLife 12 (2023)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. eLife 12 (2023)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. eLife 12 (2023)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. eLife 12 (2023)
Serkan Sayin, Brittany Rosener, Carmen G Li, Bao Ho, Olga Ponomarova, Doyle V Ward, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cells. eLife 12 (2023)
Brittany Rosener, Serkan Sayin, Peter O Oluoch, Aurian P García González, Hirotada Mori, Albertha J M Walhout, Amir Mitchell
Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the Caenorhabditis elegans host. eLife 9 (2020)
Orna Dahan, Bat-Shahar Dorfman, Serkan Sayin, Brittany Rosener, Tiffany Hua, Anat Yarden, Amir Mitchell
Harnessing robotic automation and web-based technologies to modernize scientific outreach. PLoS biology 17 (6) (2019)